Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Job posting
View:
Post by jh1970 on Nov 08, 2023 12:10pm

Job posting

Project Manager, Technical Operations

Reporting To:

Senior Project Manager

Summary:

The Project Manager will support several manufacturing, analytical and R&D projects; oversee collaborations with CMOs and Universities.
From Onc web.
Comment by Noteable on Nov 08, 2023 12:41pm
A Senior Project Manager was hired in September 2023. Looks like ONCYs Phase 3 pancreatic cancer study is moving to a Full Go.
Comment by Azzak34 on Nov 08, 2023 2:05pm
So we're hiring while most other biotech are laying off? Sounds like we're going to be just fine!!! 
Comment by Noteable on Nov 08, 2023 8:01pm
Onward and upwards to Accelerated Approvals.
Comment by Buckhenry on Nov 08, 2023 2:36pm
Meanwhile oncy is down some 20% since last week....
Comment by Azzak34 on Nov 08, 2023 2:44pm
You'd better sell all your shares then. 
Comment by fox7mf on Nov 09, 2023 8:52am
So PanCan is reevaluating (no money?) and Oncy needs a major partnership right away. The fact that ph3 keeps getting pushed back (best case scenario a June start) served as an indication this might happen. 
Comment by fox7mf on Nov 09, 2023 8:56am
A major positive of this news is that it just may indicate that the BP ( Roche, Merck) may want complete control of the trial as they are providing product. Who knows, but a big positive NR may follow in short order...FDA AA or big partnership or buyout. GL.
Comment by Journeytc on Nov 09, 2023 9:12am
Personally, I'm glad PanCan is gone.   I was pissed ONC found another way to delay and distract themselves in the phase 3 startup with the PanCan entry.   The 65 million is pocket change in relation to potential near term  revenues.  This withdrawal gives focus and puts us back on track.     Pancreatic trial outcomes speak for themselves.  The ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities